Ticagrelor overcomes high platelet reactivity in patients with acute myocardial infarction or coronary artery in-stent restenosis: a randomized controlled trial.
about
Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial.Development of local clinical practice guidelines in the real world: an evolving scene in China.Ticagrelor Reduces Thromboinflammatory Markers in Patients With Pneumonia
P2860
Ticagrelor overcomes high platelet reactivity in patients with acute myocardial infarction or coronary artery in-stent restenosis: a randomized controlled trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Ticagrelor overcomes high plat ...... a randomized controlled trial.
@ast
Ticagrelor overcomes high plat ...... a randomized controlled trial.
@en
type
label
Ticagrelor overcomes high plat ...... a randomized controlled trial.
@ast
Ticagrelor overcomes high plat ...... a randomized controlled trial.
@en
prefLabel
Ticagrelor overcomes high plat ...... a randomized controlled trial.
@ast
Ticagrelor overcomes high plat ...... a randomized controlled trial.
@en
P2093
P2860
P356
P1433
P1476
Ticagrelor overcomes high plat ...... a randomized controlled trial.
@en
P2093
Junmei Liu
Xianxian Zhao
Yawei Yang
Yongwen Qin
P2860
P2888
P356
10.1038/SREP13789
P407
P577
2015-09-09T00:00:00Z